Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BBH vs. SHPAX: which is better?

Bottom line

BBH vs SHPAX: the short answer

BBH (VanEck Biotech ETF) and SHPAX (Health & Biotechnology Portfolio) are quite different portfolios: only about 22% of their top holdings (by weight) are shared.

BBH is cheaper at 0.35% vs 3% — a difference of $265 a year per $10,000 invested.

Over five years, SHPAX returned +3.1% a year vs +2.7% for BBH (reporting dates differ).

SHPAX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

BBH vs SHPAX side by side

BBHSHPAX
TypeETFMutual fund
Fund familyVanEckSaratoga Advantage
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%3%
Annual cost per $10k$35$300
10-yr cost on $10k (prospectus)$443$3,702
Max front loadNone5.75%
12b-1 fee——
1-yr return+21.2%−5.5%
5-yr return (annualized)+2.7%+3.1%
10-yr return (annualized)+4.5%+4.1%
Best quarter+27.6%+15.0%
Worst quarter−18.2%−13.0%
Net assets (fund)$395.6M$10.5M
Number of holdings2529
Portfolio turnover19%22%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBBHSHPAXDifference
2024−4.4%+0.3%−4.7%
2023+3.9%−0.4%+4.2%
2022−15.1%+2.0%−17.1%
2021+11.8%+16.7%−4.9%
2020+22.1%+3.6%+18.4%
2019+25.8%+16.2%+9.6%
2018−10.2%−5.5%−4.8%
2017+16.6%+12.0%+4.7%
2016−15.0%−2.0%−13.1%

Source: Fund prospectus bar charts

Holdings overlap

6 of BBH's top 25 holdings also appear in SHPAX's top 25.

Shared top holdings
HoldingBBHSHPAX
Amgen Inc15.25%5.04%
Gilead Sciences Inc12.79%3.94%
Vertex Pharmaceuticals Inc9.10%3.36%
Regeneron Pharmaceuticals Inc6.21%3.93%
United Therapeutics Corp2.83%6.17%
Incyte Corp2.49%2.89%

Source: SEC Form N-PORT

BBH top 10

  1. Amgen Inc — 15.25%
  2. Gilead Sciences Inc — 12.79%
  3. Vertex Pharmaceuticals Inc — 9.10%
  4. Regeneron Pharmaceuticals Inc — 6.21%
  5. Revolution Medicines Inc — 5.27%
  6. Argenx SE — 4.97%
  7. Natera Inc — 4.92%
  8. IQVIA Holdings Inc — 4.31%
  9. Alnylam Pharmaceuticals Inc — 3.83%
  10. Biogen Inc — 3.63%

SHPAX top 10

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. United Therapeutics Corp — 6.17%
  4. Amgen Inc — 5.04%
  5. Mckesson Corp — 4.90%
  6. Lantheus Holdings Inc — 4.64%
  7. Exelixis Inc — 4.55%
  8. Novartis Ag — 4.50%
  9. Cencora Inc — 4.33%
  10. Gilead Sciences Inc — 3.94%

FAQ

What is the difference between BBH and SHPAX?
BBH (VanEck Biotech ETF) and SHPAX (Health & Biotechnology Portfolio) are quite different portfolios: only about 22% of their top holdings (by weight) are shared. BBH is cheaper at 0.35% vs 3% — a difference of $265 a year per $10,000 invested.
Which is cheaper, BBH or SHPAX?
BBH has the lower expense ratio (0.35%).
Should I own both BBH and SHPAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.